Joaquin Duato

Joaquin Duato (born April 1962) is a Spanish-American business executive. Duato is a dual citizen of Spain and the United States.[2] He is the chairman and chief executive officer (CEO) of Johnson & Johnson, an American multinational conglomerate.[3] He is the eighth person to serve as CEO of Johnson & Johnson since it became a publicly-traded company in 1944.

Joaquin Duato
BornApril 1962
CitizenshipSpain
USA
EducationESADE Business School (MBA)
Thunderbird School of Global Management (Master of International Management)
OccupationBusinessman
Years active1989-Present[1]
TitleChairman and Chief Executive Officer of Johnson & Johnson
TermJanuary 2022 - present
Children2

Early life and education

Duato grew up in Valencia, Spain. His career in healthcare was influenced by his family. His mother was a nurse, his grandfather was a pediatrician, and his grandmother a pharmacist. Duato is trilingual, speaking English, Spanish, and Italian. Duato received a Master of Business Administration from ESADE Business School in Barcelona, Spain, and a Master of International Management from the Thunderbird School of Global Management in Phoenix, Arizona.[4]

Career

Duato began his career in Johnson & Johnson in 1989 when he joined Janssen Pharmaceutica in Spain.[5] After moving to the USA in 2002, Duato was appointed Executive Vice President, Worldwide Chairman, Pharmaceuticals in 2011. His growth strategy led to the turnaround of Johnson & Johnson’s struggling pharmaceutical business in the early 2000s.[4] In 2018 when he was promoted to Vice-Chairman of Johnson & Johnson’s executive committee, he led the pharmaceuticals and consumer product divisions and oversaw supply-chain and technology operations.[5][6] He also served as interim Chief Information Officer.[4] Duato was appointed CEO in August 2021 which became effective on January 3, 2022. He was also appointed to the company’s board of directors.[7][8] In November 2022, he was elected to chair the Board of Directors, effective January 2023.[9]

Duato was the executive sponsor of the company's African Ancestry Leadership Council.[10]

Board membership and honors

Joaquin Duato is a board member of the U.S. Spain Council and previously served on boards with UNICEF USA, Tsinghua University School of Pharmaceutical Sciences, and the Hess Corporation.[6] Duato was past chair of Pharmaceutical Research and Manufacturers of America (PhRMA).[6] Duato was Healthcare Businesswomen’s Association Honorable Mentor honoree and EVP in 2017.[11] In 2021, Duato was ranked #3 on the NJBIZ Manufacturing Power 50 list.[12]

References

  1. "5 Things to Know About Johnson & Johnson's New CEO Joaquin Duato". 16 June 2023. Retrieved 2023-06-16.
  2. Rosenbaum, Eric (2022-03-30). "Next decade will transform health care more than past century: Johnson & Johnson CEO". CNBC. Retrieved 2022-06-15.
  3. Nathan-Kazis, Josh. "J&J's CEO Plans to Step Down. Analysts Expect a Smooth Transition". www.barrons.com. Retrieved 2022-07-06.
  4. "The Architect of J&J's Breakup Bets on Tech for the Future of Drugs". Bloomberg.com. 2022-04-29. Retrieved 2022-06-15.
  5. "A Look Inside J&J's Partnering & Innovation-Building Model". www.lifescienceleader.com. Retrieved 2022-06-15.
  6. "J&J CEO Steps Down, Taps Successor Joaquin Duato". BioSpace. Retrieved 2022-06-15.
  7. "J&J's New Insider CEO Brings Expertise From Crucial Pharma Post". Bloomberg.com. 2021-08-19. Retrieved 2022-06-15.
  8. "Johnson & Johnson adds vice chairman to leadership". nj. Associated Press. 2010-12-15. Retrieved 2022-06-15.
  9. "Johnson & Johnson Names CEO Joaquin Duato as Chairman of the Board". Yahoo Finance. 2022-11-30. Retrieved 2023-06-16.
  10. Rivas, Kayla (2021-08-20). "J&J's new CEO Joaquin Duato: What to know". FOXBusiness. Retrieved 2022-06-15.
  11. "J&J's Joaquin Duato: Diversity is 'essential'". MM+M - Medical Marketing and Media. 2017-05-08. Retrieved 2022-06-15.
  12. "Presenting the 2021 Manufacturing Power 50". NJBIZ. 2021-12-13. Retrieved 2022-06-15.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.